Republished Education in Heart: New P2Y12 inhibitors

被引：0
|
作者：
Storey, Robert F. [1 ]
机构：
[1] Univ Sheffield, Dept Cardiovasc Sci, Sheffield S10 2RX, S Yorkshire, England
来源：
POSTGRADUATE MEDICAL JOURNAL | 2012年 / 88卷 / 1035期
关键词：
ACUTE CORONARY SYNDROMES; OUTCOMES PLATO TRIAL; PLATELET INHIBITION; RECEPTOR ANTAGONIST; DOSE CLOPIDOGREL; TICAGRELOR; INTERVENTION; PRASUGREL; TOLERABILITY; SAFETY;
D O I：
10.1136/pgmj.2009.184242rep
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：49 / 54
页数：6
相关论文
共 50 条
  • [21] P2Y12 inhibitors: do they increase cancer risk?
    Fierro, Joseph J.
    Cave, Brandon
    Khouzam, Rami N.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (17)
  • [22] Central Sleep Apnea in Patients With Coronary Heart Disease Taking P2Y12 Inhibitors
    Tzeng, William S.
    Klein, Christian F.
    Roth, Robert H.
    Cho, Yeilim
    Munagala, Rohit
    Bonner, Heather
    Mazimba, Sula
    Khayat, Rami
    Healy, William
    Lobo, Jennifer M.
    Kapur, Vishesh K.
    Kwon, Younghoon
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 83 (01) : 126 - 130
  • [23] Pharmacology of the New P2Y12 Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties
    Nicola Ferri
    Alberto Corsini
    Stefano Bellosta
    Drugs, 2013, 73 : 1681 - 1709
  • [24] Pharmacology of the New P2Y12 Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties
    Ferri, Nicola
    Corsini, Alberto
    Bellosta, Stefano
    DRUGS, 2013, 73 (15) : 1681 - 1709
  • [25] Central Sleep Apnea in Patients with Coronary Heart Disease Taking P2Y12 Inhibitors
    Klein, C.
    Tzeng, W.
    Roth, R.
    Lobo, J. M.
    Cho, Y.
    Healy, W. J.
    Mazimba, S.
    Cho, Y.
    Kwon, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [26] State of the art of new P2Y12 antagonists
    Marco Cattaneo
    Gian Marco Podda
    Internal and Emergency Medicine, 2010, 5 : 385 - 391
  • [27] State of the art of new P2Y12 antagonists
    Cattaneo, Marco
    Podda, Gian Marco
    INTERNAL AND EMERGENCY MEDICINE, 2010, 5 (05) : 385 - 391
  • [28] Response Variability to P2Y12 Receptor Inhibitors Expectations and Reality
    Siller-Matula, Jolanta M.
    Trenk, Dietmar
    Schroer, Karsten
    Gawaz, Meinrad
    Kristensen, Steen D.
    Storey, Robert F.
    Huber, Kurt
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (11) : 1111 - 1128
  • [29] Answer Regarding: Potent P2Y12 Inhibitors and Bleeding Complications
    Akinci, Sinan
    Coner, Ali
    Akbay, Ertan
    Adar, Adem
    Muderrisoglu, Haldun
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2022, 50 (07): : 545 - 546
  • [30] P2Y12 inhibitors in neuroendovascular surgery: An opportunity for precision medicine
    Rosengart, Axel
    Collins, Malie K.
    Hendrix, Philipp
    Uber, Ryley
    Sartori, Melissa
    Jain, Abhi
    Mao, Jennifer
    Goren, Oded
    Schirmer, Clemens M.
    Griessenauer, Christoph J.
    INTERVENTIONAL NEURORADIOLOGY, 2021, 27 (05) : 682 - 694
12345